ロード中...
Does Combination Therapy with Statins and Fibrates Prevent Cardiovascular Disease in Diabetic Patients with Atherogenic Mixed Dyslipidemia?
Type 2 diabetes mellitus (T2DM) is associated with the development and progression of cardiovascular disease (CVD). Statins have an established efficacy in the management of dyslipidemia primarily by decreasing the levels of low-density lipoprotein cholesterol and thus decreasing CVD risk. They also...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SBDR - Society for Biomedical Diabetes Research
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063095/ https://ncbi.nlm.nih.gov/pubmed/24380091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2013.10.171 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|